

Built by Clinicians. Backed by Science. Driven by Precision.
Meet the team behind Somnus Scientific

Prof Tim Craft
Co-Founder & CEO
Consultant anaesthetist with 35+ years’ experience in the UK and USA. Co-founder of ISO 13485-accreditedAnaesthetic Medical Systems Ltd, a regulated MedTech manufacturer. Brings deep clinical insight and proven device commercialisation experience to Somnus.

Dr Mark O’Connell
Co-Founder & CTO
Clinical pharmacology and drug monitoring expert with 35+ years’ experience. Co-founder of ProbeScientific Ltd, an ISO 13485-accredited MedTech company with licensed products. Author of 50+ scientific papers and named inventor on multiple patents.

Denis Lonergan
Co-Founder & CFO
Serial investor and experienced life sciences finance director. Investor-director across multiple MedTech and biotech companies. Brings deep expertise in early-stage growth, capital structuring, and financial governance.
Advised by International Leaders in Medicine and Innovation.
Meet the advisory board and academic partners.

Professor
Carol Peden
Academic anesthesiologist involved in health systems research and innovation.

Professor
Jerry Nolan
Hospital consultant working equally between anaesthesia and intensive care.

Professor Mark Tooley FREng
Formally, Head of Medical Physics and Director of R&D at an acute hospital.

Professor
John Sear
Professor of Anaesthetics Emeritus, University of Oxford, UK.

Professor
Mike Parr
Director of Intensive Care and Clinical Director, Macquarie University Hospital.

Patrick Finnemore
35 year’s experience of developing and building medical technology.

Dr Sarah Varga, Clinical
Academic nurse and Critical Care Rehabilitation Coordinator.

Professor Janice Kiely
Co-founder and Director of the Institute of Bio-Sensing Technology (IBST).

Professor Richard Luxton
Co-founder and Director of Institute of Bio-Sensing Technology (IBST).

David Ferrier Research Fellow
Specialising in Bio-Sensing and Healthcare Technology.

Ibidapo Williams
Research Fellow in the Health Tech Hub at UWE.
Important Investment Information
This website contains information about Somnus Scientific Limited that is directed exclusively at professional investors.
In the United Kingdom, this information is intended only for investment professionals and high net worth entities within the meaning of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended), or other persons to whom it may lawfully be communicated.
In the United States, any investment-related information is intended solely for persons who qualify as “Accredited Investors” under Regulation D of the Securities Act of 1933.
Nothing on this website constitutes an offer to sell or a solicitation of an offer to buy any securities. Any investment will be made only on the basis of formal investment documentation provided separately.
Investments in early-stage medical technology companies are high risk. Capital is at risk and investors may lose some or all of their investment. Prospective investors should seek independent professional advice before making any investment decision.














